4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-25-088486
Options or other derivatives
- Director acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Miller-Rich Nancy Director | 2025-06-17 | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | D | ||
Loading xslF345X05/ownership.xml…